The fundamental problem with most implantable neural recording devices is the wire. Wires corrode, cause immune reactions, transmit infection risk, tether the device to external hardware, and limit where in the body you can practically put a sensor. For 50 years, every major advance in implantable neural monitoring has had to work around this constraint.
Neural dust solves it by eliminating wires and batteries entirely. Developed at UC Berkeley, neural dust devices are free-floating piezoelectric sensors small enough to inject through a needle. They harvest energy from external ultrasound pulses and backscatter their neural recordings on the same ultrasound channel — no radio frequency signals, no batteries, no percutaneous leads.
How It Works
Each neural dust mote contains a piezoelectric crystal that converts the mechanical energy of an ultrasound pulse into electricity, powering the onboard electronics. The mote records the local field potential or electromyographic signal, modulates that recording onto the reflected ultrasound pulse, and sends it back to a transceiver worn on the skin surface above. The external transceiver both powers and reads the implanted sensors simultaneously.
Neural Dust Specs
- →0.8 mm³ — volume of first-generation neural dust mote (about the size of a grain of sand)
- →No battery — powered entirely by external ultrasound harvesting
- →Injectable — can be delivered through a standard 18-gauge needle
- →Peripheral + CNS — demonstrated in sciatic nerve, spinal cord, and brain of rats
Applications Beyond the Brain
Most current neural recording technology focuses on the brain. Neural dust’s injectable, wireless, batteryless architecture makes it practical for the peripheral nervous system — the sciatic nerve, vagus nerve, the enteric nervous system of the gut — locations where conventional implants have never been feasible. A network of neural dust motes seeded throughout the body could provide continuous bioelectric monitoring of organ function without any surgery more invasive than an injection.
What This Means For The Future
The UC Berkeley team is now developing second-generation motes targeting sub-100 micron dimensions — small enough to embed in individual fascicles of a peripheral nerve. At that scale, neural dust becomes a viable platform for closed-loop bioelectronic medicine: reading organ-specific nerve signals and delivering targeted electrical therapy to the same structures, entirely from outside the skin.
Source: Seo et al., Neuron (2016) · Neely et al., UC Berkeley (2024)
Credit: Hitesh Dewasi on Unsplash